Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SAINT-LAURENT, CANADA--(Marketwired - Dec. 14, 2016) - IntelGenx Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), and RedHill Biopharma Ltd. (NASDAQ:RDHL)(TASE:RDHL), today announced the signing of...
-
SAINT-LAURENT, CANADA--(Marketwired - Dec. 1, 2016) - IntelGenx Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today strengthened its relationship with Chemo Group ("Chemo") by signing a term...
-
SAINT LAURENT, QUEBEC--(Marketwired - Nov. 21, 2016) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today announced the signing of a binding term sheet for...
-
SAINT-LAURENT, QUEBEC--(Marketwired - Nov. 10, 2016) - IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported its third quarter 2016...
-
SAINT-LAURENT, QUEBEC--(Marketwired - Nov. 1, 2016) - IntelGenx Technologies Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today announced that it will release its third quarter 2016 results for...
-
SAINT-LAURENT, CANADA--(Marketwired - Sept. 21, 2016) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT), and RedHill Biopharma Ltd. (NASDAQ:RDHL)(TASE:RDHL), today announced that they have...
-
SAINT-LAURENT, QUEBEC--(Marketwired - Sept. 16, 2016) - IntelGenx Technologies Corp. ("IntelGenx", or the "Company") (TSX VENTURE:IGX)(OTCQX:IGXT) announced today that the Company's Board...
-
SAINT-LAURENT, QUEBEC--(Marketwired - Sept. 12, 2016) - IntelGenx Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today announced that they have entered into a licensing, development and supply...
-
SAINT-LAURENT, CANADA--(Marketwired - Sept. 7, 2016) - IntelGenx Corp., (TSX VENTURE:IGX) (OTCQX:IGXT), today announced that Dr. Horst Zerbe, President and Chief Executive Officer, will...
-
SAINT-LAURENT, CANADA--(Marketwired - Aug. 22, 2016) - IntelGenx Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today announced the successful completion of a pilot clinical study for Montelukast...